Ligand Pharmaceuticals Incorporated (LGND)
Receivables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 167,133 | 131,314 | 196,245 | 277,133 | 186,419 |
| Receivables | US$ in thousands | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue ÷ Receivables
= $167,133K ÷ $—K
= —
The receivables turnover ratio for Ligand Pharmaceuticals Incorporated appears to be unavailable for the years specified (December 31, 2020 to December 31, 2024) as denoted by the dash symbol "—". This indicates a lack of specific data on the company's receivables turnover during these periods. Consequently, a thorough analysis of this particular ratio for Ligand Pharmaceuticals Incorporated cannot be conducted based on the information provided. It is essential to have access to accurate and up-to-date financial data in order to effectively evaluate the efficiency of the company in managing its receivables.
Peer comparison
Dec 31, 2024